We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guidance Advises Generics Makers on Impurities in Drug Substances
Guidance Advises Generics Makers on Impurities in Drug Substances
August 3, 2009
A final guidance for generic-drug makers revises recommendations on what chemistry, manufacturing and controls information on drug substances produced by synthesis should be included in ANDAs, drug master files and ANDA supplements.